Patch Notes for Society #003: Healthcare Affordability and the Bill Nobody Owns

Patch Notes for Society #003: Healthcare Affordability and the Bill Nobody Owns

America does not have one healthcare affordability problem. It has a system of prices, premiums, deductibles, drug costs, denied claims, administrative friction, medical debt, public budgets, employer benefit costs, and provider capacity that keeps moving the pain around.

This is a public systems essay. It is not medical advice, clinical guidance, insurance advice, benefits advice, legal advice, debt advice, or a recommendation for any individual coverage, treatment, billing, or claims decision.

The System We Inherited

Healthcare is where almost everyone agrees the system is broken and almost no one agrees which broken part to fix first.

One person says the problem is insurance. Another says hospitals. Another says drug companies. Another says government. Another says patients use too much care. Another says people skip care because they already pay too much. Another says administrative waste is the obvious target. Another says some of that administration is how the system controls fraud, risk, quality, and utilization.

Many of these claims can be partly true.

That is the first clue that healthcare affordability is not one bug.

It is a stack of bugs.

The United States built a healthcare financing system where the person receiving care often does not know the price, the person paying the bill may be an employer or public program, the person negotiating the rate may be an insurer, the person setting the charge may be a provider system, the person deciding coverage may be a plan administrator, and the person feeling the pain may be a family looking at a deductible, a denied claim, a drug copay, or a collections notice.

Then we argue as if there is one clean lever.

There is not.

The first Patch Notes job is to map the machine before arguing about the patch.

The Bug

The bug is not simply that healthcare costs too much.

The bug is that the system can make every actor feel squeezed while still failing the patient.

Patients feel it through premiums, deductibles, copays, drug costs, surprise or confusing bills, narrow networks, denied claims, medical debt, delayed care, and skipped care.

Employers feel it through benefit budgets and compensation tradeoffs.

Workers feel it through paychecks, payroll deductions, deductibles, and job lock.

Clinicians feel it through documentation, prior authorization, claims friction, productivity pressure, staffing shortages, and burnout.

Hospitals and physician groups feel it through labor costs, payer mix, uncompensated care, negotiated rates, public payment rules, debt, service-line pressure, and capital needs.

Insurers feel it through risk pools, premium pressure, claims costs, utilization management, networks, regulation, and administrative obligations.

States and the federal government feel it through Medicare, Medicaid, subsidies, public employees, tax exclusions, budgets, and political backlash.

Drug companies, PBMs, pharmacies, device firms, billing vendors, and data systems each sit inside the flow.

The system is expensive in the aggregate and still unaffordable at the point of use.

That should make us suspicious of any reform that promises savings without saying who pays less, who gets paid less, who does more work, who loses access, who absorbs the transition cost, and how patients will know the system improved.

Why The Bug Persists

The bug persists because healthcare cost is not a single number.

National health expenditure is one number. Premiums are another. Deductibles are another. Out-of-pocket costs are another. Employer contributions are another. Public spending is another. Hospital prices are another. Drug list prices and net prices may tell different stories. Administrative cost can be measured by spending category, staff time, paperwork burden, claim friction, or patient navigation pain.

When people pick different numbers, they can have different arguments while all believing they are talking about "healthcare costs."

The bug also persists because costs can move.

Lower one premium by raising a deductible, and the headline may improve while the sickest families face more risk.

Cut one public payment rate too bluntly, and the public budget may improve while a fragile provider reduces access.

Push utilization management harder, and claims spending may fall while denials, appeals, clinician workload, and delayed care rise.

Lower a drug's net price through rebates, and patients may still face unaffordable cost sharing if benefit design does not pass savings through clearly.

Simplify one administrative process without redesigning the workflow, and the work may move from payer staff to clinicians, patients, billing offices, or call centers.

Constrain one price, and the system may respond through coding, facility fees, service mix, consolidation, narrower networks, or new contract terms.

Healthcare is very good at adaptation. That is why a reform can look successful on one dashboard while patients still feel trapped.

The Numbers Are Not Enough

CMS National Health Expenditure Accounts are the right place to start for the official spending map. They help separate spending by service category and payer. That matters because "healthcare" includes hospitals, physicians and clinical services, prescription drugs, long-term care, insurers, public programs, and other categories that should not be collapsed into one bucket.

KFF, Peterson-KFF Health System Tracker, the Commonwealth Fund, and the Health Care Cost Institute provide useful public anchors for affordability, employer coverage, medical debt, international comparisons, and employer-sponsored insurance spending.

But spending tables are not the whole story.

A family does not experience the system as a national chart. It experiences the system as a premium, a deductible, a pharmacy counter, a denied claim, a confusing bill, a collection notice, a narrow network, a delayed appointment, or the decision not to seek care.

That is why the first public scope should be the patient affordability interface.

Start where people feel the failure. Then map the cost drivers behind it.

What This Is Not Saying

This is not saying there is one villain.

It is not saying insurers are innocent or guilty as a category.

It is not saying hospitals are the whole problem.

It is not saying drug companies or PBMs are the whole problem.

It is not saying government can fix the system just by paying more or paying less.

It is not saying every high price is waste.

It is not saying every administrative task is unnecessary.

It is not saying patients should be exposed to more financial risk so they shop better.

It is not saying lower spending is automatically better if access, quality, innovation, rural care, safety-net capacity, or clinician capacity collapses.

It is not saying single payer, a public option, market competition, antitrust, drug negotiation, value-based care, price transparency, medical-debt protection, or administrative simplification should be judged by slogan.

It is saying that any serious affordability plan has to explain the flow of money, the flow of power, the flow of work, and the flow of harm.

Who Gets Hurt

Patients get hurt when affordability is measured only as system spending and not as lived exposure.

A person can be insured and still delay care because the deductible is too high. A family can have coverage and still face unaffordable drug costs. A worker can have an employer plan and still see wages pressured by benefit costs. A patient can receive necessary care and still spend months fighting a bill.

Clinicians get hurt when savings are achieved by moving unpaid administrative work into the exam room.

If the affordability plan creates more documentation, more prior authorization, more portal messages, more coding pressure, more patient navigation tasks, and more appeals without more capacity, the system has not simplified care. It has hidden labor inside clinical time.

Employers and workers get hurt when employer-sponsored insurance is treated as free money.

Employer contributions are part of compensation economics. The worker may not see the full cost directly, but that does not mean the cost disappears.

Rural communities and safety-net patients get hurt when price reform ignores provider fragility.

Some prices reflect market power. Some revenue supports service lines that already operate close to the edge. The policy problem is to separate excessive prices from fragile access, not to pretend every payment cut has the same effect.

Public budgets get hurt when reforms move cost from private premiums to taxes without lowering underlying prices, improving access, or reducing patient burden.

Patients also get hurt when debt relief is treated as a substitute for affordability.

Medical-debt protection matters. Billing reform matters. Charity care and collections rules matter. But if the underlying prices, coverage design, and claims process remain broken, debt relief becomes cleanup after injury.

Who Benefits

The current system benefits from opacity.

Not because every actor is malicious. Because opacity gives each actor room to defend its own slice.

Providers can say insurers deny too much.

Insurers can say providers charge too much.

Drug companies can say PBMs and insurers control patient cost.

PBMs can say they negotiate savings.

Employers can say they are offering coverage.

Governments can say public programs are under fiscal pressure.

Patients are left trying to understand a bill that is downstream of all of them.

The system also benefits actors with bargaining power.

Consolidated providers can sometimes negotiate higher prices. Large payers can sometimes dictate terms smaller actors cannot. PBMs and pharmacy networks can shape access and incentives in ways patients rarely see. Vendors and administrative systems can become embedded because complexity creates its own infrastructure.

That does not mean the answer is to attack every intermediary.

It means any reform should ask: who has power, who can pass costs along, who cannot, and who is forced to absorb the failure?

The Better System

A better healthcare affordability system would optimize for patient affordability, total cost discipline, useful care, access, quality, workforce capacity, and public legitimacy at the same time.

That sounds obvious. It is not how the current debate usually works.

The current debate often optimizes one metric and then discovers the side effect later.

A better system would separate at least six levers.

First: prices.

What are hospitals, physicians, drug companies, pharmacies, and other providers paid? Which prices reflect market power? Which reflect necessary capacity? Which vary by site of care for reasons patients cannot see? Which can be regulated, negotiated, made site-neutral, or made more competitive without reducing access?

Second: utilization.

How much care is delivered? Which care is high-value, low-value, duplicative, delayed, avoided, or substituted into emergency settings because earlier care was unaffordable or unavailable?

Third: insurance design.

What do premiums, deductibles, copays, coinsurance, networks, prior authorization, claims rules, and appeals do to patient behavior and patient harm? Does the plan protect people when they are sick, or only look affordable while they are healthy?

Fourth: market structure.

Where do consolidation, local provider scarcity, payer bargaining, employer purchasing, and public payment rules shape prices and access?

Fifth: administration.

Which billing, coding, claims, quality, fraud-control, coordination, and authorization tasks are necessary? Which are waste? Which produce patient or clinician harm? Which can be standardized or automated without creating new burden elsewhere?

Sixth: capacity and quality.

Does the reform preserve timely access, rural and safety-net care, primary care, specialist capacity, nursing and clinician staffing, innovation where it has real value, and outcomes patients can feel?

The better system is not a slogan. It is a dashboard with hard tradeoffs and pause conditions.

The Migration Plan

Start with a public affordability map.

For every reform proposal, require four tables before the slogan:

• who pays today;
• who gets paid today;
• who does the administrative work today;
• where patients feel pain today.

Then require the same four tables for the proposed future state.

If the reform cannot say what changes for patients, employers, clinicians, providers, insurers, public programs, and drug/PBM actors, it is not ready.

Second, build a patient affordability dashboard beside every spending dashboard.

Track premiums, deductibles, out-of-pocket exposure, drug cost sharing, delayed or skipped care due to cost, medical debt, denied claims, appeal outcomes, time to care, network adequacy, billing confusion, and patient-reported affordability.

Do not let national spending growth stand alone.

Third, separate price reform by market and provider type.

Hospital market power, physician consolidation, facility fees, site-of-care payment differences, rural hospital fragility, safety-net finance, and public/private payer gaps are not one thing. A reform that is right for a high-priced consolidated urban system may be wrong for a rural hospital with thin margins and limited workforce.

Fourth, redesign administrative workflows at the process level.

Do not announce "administrative simplification" as if the work disappears by decree. Map prior authorization, claims, coding, documentation, appeals, billing, patient navigation, quality reporting, fraud controls, and clinician time. Remove waste. Preserve necessary safeguards. Measure where the work lands after the change.

Fifth, make drug and PBM reform legible to patients.

Separate list prices, net prices, rebates, formulary design, specialty drugs, pharmacy access, patient cost sharing, and public negotiation. A reform that improves a behind-the-scenes price but leaves the patient unaffordable at the pharmacy counter is incomplete.

Sixth, treat employer-sponsored insurance as household affordability.

Employer premiums, employee contributions, deductibles, and wage pressure belong in the same map. Employer contributions are not outside the household economy just because they are less visible.

Seventh, protect patients after bills arrive, but do not stop there.

Medical-debt protections, billing reform, charity-care enforcement, clear appeals, and collection limits can reduce harm. They should be paired with upstream price, coverage, and claims reform so the system is not simply building a better ambulance for unaffordable bills.

Eighth, pilot with stop conditions.

Every affordability pilot should say in advance what would force a pause: delayed care rises, medical debt persists, denials increase, network adequacy worsens, clinician burden grows, rural access deteriorates, safety-net capacity falls, public budgets absorb costs without patient relief, or savings appear only because work moved off the books.

What Could Go Wrong

A healthcare affordability reform can fail in predictable ways.

It can lower premiums while raising deductibles.

It can reduce public spending while weakening access.

It can cut provider payments without distinguishing monopoly pricing from fragile capacity.

It can simplify payer administration by adding clinician work.

It can reduce utilization by delaying needed care.

It can make a public program cheaper by making private coverage more expensive, or the reverse.

It can protect patients from medical debt after the fact while leaving prices and coverage design untouched.

It can attack drug list prices while missing net prices, rebates, formularies, pharmacy access, and patient out-of-pocket exposure.

It can overpromise value-based care and then reward coding intensity instead of better outcomes.

It can use price transparency as if transparency alone creates bargaining power for a patient in a hospital bed.

It can use competition language in markets where patients cannot shop, providers are already consolidated, or the local alternative does not exist.

It can use government payment power without a migration plan for workforce, access, and provider solvency.

It can measure savings while ignoring trust.

The public will judge healthcare reform by bills, delays, denied care, access, and whether the system feels less impossible to navigate. A plan that wins an accounting argument and loses lived legitimacy will not survive.

How We Would Measure Progress

Measure cost, patient burden, access, quality, and workload together.

Track:

• total national health spending growth;
• per-capita spending;
• spending by service category and payer;
• premiums for households and employers;
• employee contribution and deductible exposure;
• out-of-pocket spending by income and health status;
• delayed or skipped care due to cost;
• medical debt and collections;
• denied claims, appeal rates, overturned denials, and time to resolution;
• prior authorization volume and time to care;
• clinician administrative time;
• hospital and physician prices by market and site of care;
• drug list prices, net prices where available, patient cost sharing, and formulary access;
• network adequacy and appointment wait times;
• rural and safety-net service availability;
• primary care access;
• quality and patient outcomes;
• public budget impact;
• employer benefit cost and wage-pressure indicators;
• patient-reported billing confusion and affordability.

The key rule: no savings claim should stand without a paired patient, access, and capacity measure.

What Readers Can Do

If you are a patient or family member, pressure the public conversation to start from the lived interface: premiums, deductibles, drug costs, denied claims, confusing bills, debt, and delayed care. The system should not be allowed to declare success while those get worse.

If you are an employer, ask whether your benefit strategy is reducing total burden or only moving cost between premiums, deductibles, wages, networks, and delayed care.

If you are a clinician or operator, name the administrative work that policy proposals hide. A reform that saves money by consuming clinical time is not simple.

If you work in insurance, benefits, hospitals, pharmacy, public programs, or health policy, make the tradeoff explicit. Which cost moves? Which actor adapts? Which metric can be gamed? Which patient harm should trigger a pause?

If you are a policymaker, do not ask only whether a reform lowers spending. Ask whether it lowers patient burden, preserves access, reduces useless complexity, protects fragile capacity, and survives institutional adaptation.

If you are a voter, be skeptical of one-villain healthcare stories. They may contain a truth, but they are rarely the whole operating system.

Reviewer Questions

This essay needs critique as it develops.

The review questions:

1. Where does this still confuse spending, prices, premiums, deductibles, out-of-pocket burden, public budgets, and medical debt?
2. Which cost driver is overstated?
3. Which cost driver is understated?
4. What patient pain point should lead: premiums, deductibles, drug costs, denied claims, medical debt, delayed care, or billing confusion?
5. Which metric would be easiest for the system to game?
6. Which reform would most likely shift work onto clinicians?
7. Which reform would most likely damage access if implemented bluntly?
8. How should the paper distinguish market-power prices from fragile provider capacity?
9. What source or evidence lane must be added before the next revision?
10. What should be cut or revised?

Patch Notes only works if the notes get better.

Sources And Next Reading

• CMS, National Health Expenditure Data: https://www.cms.gov/data-research/statistics-trends-and-reports/national-health-expenditure-data
• CMS, National Health Expenditures 2024 Highlights: https://www.cms.gov/files/document/highlights.pdf
• KFF, Health Care Costs and Affordability: https://www.kff.org/topic/health-costs/
• KFF, 2025 Employer Health Benefits Survey: https://www.kff.org/health-costs/2025-employer-health-benefits-survey/
• KFF / Peterson Health System Tracker: https://www.healthsystemtracker.org/
• Commonwealth Fund, U.S. Health Care from a Global Perspective: https://www.commonwealthfund.org/publications/issue-briefs/2024/jan/us-health-care-global-perspective-2022
• Health Care Cost Institute: https://healthcostinstitute.org/
• KFF, Medical Debt: https://www.kff.org/health-costs/the-burden-of-medical-debt-in-the-united-states/